newsfilter
← Latest News
PR Newswire·

BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences Innovation

  • Bon Natural Life Limited's subsidiary, Xi'an App-Chem Bio, formed the BON Natural Ingredients & Biomanufacturing Joint Lab with China Oat Group on Nov. 20, 2026, to advance high-quality health industry development.
  • The Joint Lab will establish an integrated innovation framework spanning fundamental research, pilot-scale development, standard-setting, and industrial commercialization.
  • A core objective is developing an AI-driven technological platform for natural ingredient biomanufacturing, utilizing synthetic biology as the foundation & AI as a key differentiator.
  • The collaboration aims to solve supply availability, stability, & high cost challenges for oat-derived ingredients by creating biomanufacturing technologies for beta-glucan & avenanthramides.
  • The Joint Lab will prioritize standards development through systematic testing of ingredient purity, safety, & isotopic profiles to ensure product differentiation & commercial value.
  • Bon Natural Life seeks to transition from conventional extraction to AI-driven biomanufacturing, positioning itself as an "AI-driven pioneer in digital nutrition."
  • China Oat Group contributes extensive oat value chain expertise, over ten Chinese invention patents, & multiple international patents, alongside large-scale standardized deep processing capabilities.
  • Bon Chairman Yongwei Hu stated the partnership aims to accelerate commercialization of biosynthetic innovations & deliver safe, effective health solutions to global consumers.
Company
Bon Natural Life Limited
Keywords
Bon Natural Life Limited